Filing Details

Accession Number:
0001209191-23-058404
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-12-12 19:30:27
Reporting Period:
2023-12-11
Accepted Time:
2023-12-12 19:30:27
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1419041 Forte Biosciences Inc. FBRX Pharmaceutical Preparations (2834) 261243872
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1612842 A. Paul Wagner C/O Forte Biosciences, Inc.
3060 Pegasus Park Dr., Bldg 6
Dallas TX 75247
See Remarks Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-12-11 25,000 $0.65 1,787,940 No 4 P Direct
Common Stock Acquisiton 2023-12-12 4,776 $0.65 1,792,716 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
Footnotes
  1. Represents the weighted average share price of an aggregate total of 25,000 shares purchased in the price range of $0.6199 to $0.65 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
  2. Represents the weighted average share price of an aggregate total of 4,776 shares purchased in the price range of $0.639 to $0.65 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.